Skip to main content

Publicaciones iTironet

Grupo Mónica Marazuela

  • Sebastian-Valles F, Bernaldo Madrid B, Sager C, Carrillo López E, Mera Carreiro S, Ávila Antón L, García NS, Sampedro-Nuñez MA, Díaz Pérez JÁ, Marazuela M. Chronic Treatment with Somatostatin Analogues in Recurrent Type 1 Gastric Neuroendocrine Tumors. Biomedicines. 2023 Mar 13;11(3):872. doi: 10.3390/biomedicines11030872. PMID: 36979851; PMCID: PMC10045480.
pubmed
  • Sacristán-Gómez P, Serrano-Somavilla A, Castro-Espadas L, Sánchez de la Blanca Carrero N, Sampedro-Núñez M, Muñoz-De-Nova JL, Molina-Jiménez F, Rosell A, Marazuela M, Martínez-Hernández R. Evaluation of Epithelial-Mesenchymal Transition Markers in Autoimmune Thyroid Diseases. Int J Mol Sci. 2023 Feb 8;24(4):3359. doi: 10.3390/ijms24043359. PMID: 36834770; PMCID: PMC9965822.
pubmed
  • Martínez-Hernández R, Marazuela M. MicroRNAs in autoimmune thyroid diseases and their role as biomarkers. Best Pract Res Clin Endocrinol Metab. 2023 Mar;37(2):101741. doi: 10.1016/j.beem.2023.101741. Epub 2023 Feb 8. PMID: 36801129.
pubmed
  • Sánchez-Gutiérrez R, Martínez-Hernández R, Serrano-Somavilla A, Sampedro-Nuñez M, Mendoza-Pérez A, de Nova JLM, Vitales-Noyola M, González-Amaro R, Marazuela M. Analysis of T follicular and T peripheral helper lymphocytes in autoimmune thyroid disease. Endocrine. 2024 Jun 15. doi: 10.1007/s12020-024-03686-7. Epub ahead of print. PMID: 38878190.
pubmed
  • Martínez-Hernández R, Sánchez de la Blanca N, Sacristán-Gómez P, Serrano-Somavilla A, Muñoz De Nova JL, Sánchez Cabo F, Heyn H, Sampedro-Núñez M, Marazuela M. Unraveling the molecular architecture of autoimmune thyroid diseases at spatial resolution. Nat Commun. 2024 Jul 13;15(1):5895. doi: 10.1038/s41467-024-50192-5. PMID: 39003267; PMCID: PMC11246508.
pubmed

Grupo Asociado Pilar Santisteban Sanz (TIROCAN).

  • Kang HS, Sara A. Grimm SA, Jothi R, Santisteban P. Jetten AM. GLIS3 regulates transcription of thyroid hormone biosynthetic genes in coordination with other thyroid transcription factors. Cell Biosci, 2023, 13:32-50 (2023). DOI: 10.1186/s13578-023-00979-8. PMID: 36793061. PMCID: PMC9930322

pubmed

  • Haderk F, Chou YT, Cech L, Fernández-Méndez C, Yu J, Olivas V, Meraz IM, Barbosa Rabago D, Kerr DL, Gomez C, Allegakoen DV, Guan J, Shah KN, Herrington KA, Gbenedio OM, Nanjo S, Majidi M, Tamaki W, Pourmoghadam YK, Rotow JK, McCoach CE, Riess JW, Gutkind JS, Tang TT, Post L, Huang B, Santisteban P, Goodarzi H, Bandyopadhyay S, Kuo CJ, Roose JP, Wu W, Blakely CM, Roth JA, Bivona TG. Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer. Nat Commun. 2024 May 3;15(1):3741. doi: 10.1038/s41467-024-47423-0. PMID: 38702301; PMCID: PMC11068778

pubmed

  • Villafuerte B, Carrasco-López C, Herranz A, Garzón L, Simón R, Natera-de-Benito D, Alikhani P, Tenorio J, García-Santiago F, Solis M, Del-Pozo Á, Lapunzina P, Ortigoza-Escobar JD, Santisteban P, Moreno JC. A Novel Missense Variant in the NKX2-1 Homeodomain Prevents Transcriptional Rescue by TAZ. Thyroid. 2024 Jul;34(7):942-948. doi: 10.1089/thy.2023.0593. Epub 2024 May 29. PMID: 38757609.

pubmed

Grupo Fátima Al-Shahrour (Grupo BU)

  • María José Jiménez-Santos1, Santiago García-Martín1, Marcos Rubio-Fernández1,2, Gonzalo Gómez-López1 and Fátima Al-Shahrour1*. Spatial Transcriptomics in Breast Cancer Reveals Tumour Microenvironment-Driven Drug Responses and Clonal Therapeutic Heterogeneity. bioRxiv. February 21, 2024. doi: 10.1101/2024.02.18.580660.

biorxiv

  • Nikolski M, Hovig E, Al-Shahrour F, Blomberg N, Scollen S, Valencia A, Saunders G. Roadmap for a European cancer data management and precision medicine infrastructure. Nat Cancer. 2024 Mar;5(3):367-372. doi: 10.1038/s43018-023-00717-6. PMID: 38321342.

pubmed